However, sustained TNF-α signaling in the tumor microenvironment has been shown to induce MUC4 expression, which masks the HER2 epitope and reduces trastuzumab efficacy, thereby facilitating immune evasion [31, 32]. This evidence concerns the gene MUC4 and neoplasm.